Ballentine Partners LLC Cuts Stock Position in Procter & Gamble Company (The) $PG

Ballentine Partners LLC lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 7.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,479 shares of the company’s stock after selling 4,241 shares during the quarter. Ballentine Partners LLC’s holdings in Procter & Gamble were worth $7,910,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Halbert Hargrove Global Advisors LLC purchased a new position in Procter & Gamble during the 3rd quarter worth $25,000. Corundum Trust Company INC acquired a new stake in Procter & Gamble in the third quarter worth about $32,000. Mid American Wealth Advisory Group Inc. purchased a new stake in shares of Procter & Gamble during the second quarter worth about $34,000. RMG Wealth Management LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $37,000. Finally, Marquette Asset Management LLC acquired a new stake in Procter & Gamble in the 3rd quarter worth approximately $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G is pushing a “Supply Chain 3.0” program (AI, automation, digital tools) expected to boost efficiency, lower costs and support margin expansion — a structural positive for future profitability. Is PG’s Supply Chain 3.0 Redefining Efficiency Through Automation?
• Positive Sentiment: P&G’s contrarian strategy in China’s baby-care market is gaining traction, supporting organic revenue recovery in a key emerging market. Fewer Babies, Higher Sales: P&G’s Contrarian Bet in China Is Working
• Positive Sentiment: The company confirmed its quarterly dividend (annualized ~$4.23; ~2.8% yield), which supports income-oriented investor demand and the “total return” case. Procter & Gamble stock page
• Positive Sentiment: Some brokers have nudged targets/rating higher (recent raised targets/Overweight calls), providing incremental bullish analyst support. Procter & Gamble (NYSE:PG) Price Target Raised to $157.00
• Neutral Sentiment: Goldman Sachs kept a Hold rating (reflecting solid fundamentals but limited near-term upside), which keeps professional opinion mixed. Procter & Gamble: Solid Fundamentals but Limited Near-Term Upside Support a Hold Rating
• Neutral Sentiment: Elevated retail/investor attention and media coverage can boost volume and volatility short-term but don’t necessarily change fundamentals. Procter & Gamble Company (The) (PG) is Attracting Investor Attention
• Neutral Sentiment: P&G insiders made no new 10b5‑1 plans in Q4 2025 — signals stability but reduces forward visibility into expected insider trades. P&G Insiders Make No New 10b5-1 Trading Plans in Q4 2025
• Negative Sentiment: A senior insider (Marc S. Pritchard) sold ~95,903 shares (~$14.5M at ~$151.15), cutting his stake materially — large insider sales can sap sentiment and add short-term selling pressure. Procter & Gamble (NYSE:PG) Insider Sells $14,495,738.45 in Stock
• Negative Sentiment: UBS trimmed its price target (cut to $161) despite keeping a favorable opinion, signaling a more cautious near-term view that can weigh on upside expectations. UBS Sees a Challenging Backdrop for Procter & Gamble (PG)

Procter & Gamble Stock Performance

PG opened at $148.49 on Wednesday. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $179.99. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.72 and a quick ratio of 0.51. The stock has a market cap of $345.09 billion, a P/E ratio of 22.00, a P/E/G ratio of 4.96 and a beta of 0.39. The firm has a fifty day moving average price of $144.83 and a 200 day moving average price of $150.37.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Thursday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.10% and a net margin of 19.30%.The company had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter in the prior year, the business posted $1.88 earnings per share. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be paid a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is currently 62.67%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PG. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Wednesday, January 7th. They set a “neutral” rating and a $150.00 price target on the stock. Barclays set a $155.00 price objective on shares of Procter & Gamble in a report on Friday, January 16th. TD Cowen lowered Procter & Gamble from a “buy” rating to a “hold” rating and raised their target price for the stock from $150.00 to $156.00 in a research note on Tuesday. UBS Group lifted their price target on Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday. Finally, BNP Paribas Exane cut their price objective on Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a report on Friday, January 16th. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average target price of $167.00.

Insider Activity

In related news, insider Marc S. Pritchard sold 95,903 shares of the firm’s stock in a transaction dated Friday, January 23rd. The shares were sold at an average price of $151.15, for a total value of $14,495,738.45. Following the transaction, the insider directly owned 182,607 shares of the company’s stock, valued at approximately $27,601,048.05. This trade represents a 34.43% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Matthew W. Janzaruk sold 725 shares of the stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total value of $108,438.25. Following the transaction, the chief accounting officer directly owned 979 shares of the company’s stock, valued at $146,429.03. The trade was a 42.55% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 96,629 shares of company stock valued at $14,604,323. Insiders own 0.20% of the company’s stock.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.